Beauty Farm Medical and Health Industry Inc. completed an on-market repurchase of 47,500 ordinary shares on 03 July 2026. The transaction, carried out under the share-buyback mandate approved on 26 June 2026, was executed at prices ranging from HKD 16.35 to HKD 17.00 per share, with a volume-weighted average price of HKD 16.8746. Total consideration amounted to approximately HKD 0.80 million.

The repurchased shares, representing 0.0191% of the 248.34 million issued shares (excluding treasury shares) outstanding before the transaction, have been retained as treasury stock. As a result, Beauty Farm’s outstanding share count fell slightly to 248.30 million, while treasury shares increased to 3.30 million. The company’s total issued share capital remains unchanged at 251.59 million shares.

Since receiving shareholder authorisation to repurchase up to 24.85 million shares, Beauty Farm has acquired 225,000 shares—equivalent to 0.09% of the issued share base on the mandate date—leaving room to repurchase a further 24.63 million shares. In line with Hong Kong Stock Exchange regulations, the company is subject to a moratorium on issuing new shares or selling treasury shares until 02 August 2026.

The board confirmed that the buyback complied with Main Board Rule 10.06 and related regulatory requirements, and that all funds related to the repurchase have been duly settled.